Literature DB >> 15950176

Cognitive characteristics of patients with borderline personality disorder: development and validation of a self-report inventory.

Babette Renneberg1, Claudia Schmidt-Rathjens, Robert Hippin, Matthias Backenstrass, Thomas Fydrich.   

Abstract

Based on cognitive concepts of personality disorders as well as on the bio-social model of borderline personality disorder (BPD), a 34-item instrument, the questionnaire of thoughts and feelings (QTF) was developed for the assessment of feelings, strategic cognitions, and assumptions characteristic for BPD. In different studies, item- and factor analyses were conducted with a dataset of N=646 clinical and non-clinical participants. Cross-sectional data as well as longitudinal data are available including several other measures on personality and personality disorders: DSM-IV SCID II dimensional score, a personality inventory (PSSI), the German version of the personality disorder beliefs questionnaire (PBQ), as well as overall severity of symptoms (GSI) of the SCL-90-R. Internal consistency of the scale is excellent, Cronbach's alpha=0.91. One-week test-retest reliability was also high r(tt)=0.81. Good convergent and discriminant validity was obtained for correlation with SCID dimensional scores and discrimination of BDP patients and other clinical and non-clinical groups. A comparison of scores in a sample of 26 patients with BPD during crisis intervention and 8 months later indicated the sensitivity of the QTF to measure change over time. Overall, the questionnaire appears to be a methodologically sound measure, valuable for research purposes as well as in clinical practice.

Entities:  

Mesh:

Year:  2005        PMID: 15950176     DOI: 10.1016/j.jbtep.2005.05.001

Source DB:  PubMed          Journal:  J Behav Ther Exp Psychiatry        ISSN: 0005-7916


  7 in total

1.  "There is not much help for mothers like me": Parenting Skills for Mothers with Borderline Personality Disorder - a newly developed group training program.

Authors:  Babette Renneberg; Charlotte Rosenbach
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2016-12-01

2.  Psychometric properties of the German version of the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) in clinical routine settings: study design and protocol of a multitrait-multimethod study.

Authors:  Jan-Peter Spies; Marcella Lydia Woud; Henrik Kessler; Heinrich Rau; Gerd Dieter Willmund; Kai Köhler; Stephan Herpertz; Simon E Blackwell; Michelle Bovin; Brian P Marx; Jan Christopher Cwik
Journal:  BMJ Open       Date:  2020-06-22       Impact factor: 2.692

3.  Rejection Sensitivity, Self-Compassion, and Aggressive Behavior: The Role of Borderline Features as a Mediator.

Authors:  Eliane Sommerfeld; Mally Shechory Bitton
Journal:  Front Psychol       Date:  2020-01-24

4.  Effectiveness of dialectic behavioral therapy in routine outpatient care: the Berlin Borderline Study.

Authors:  Christian Stiglmayr; Julia Stecher-Mohr; Till Wagner; Jeannette Meiβner; Doreen Spretz; Christiane Steffens; Stefan Roepke; Thomas Fydrich; Harriet Salbach-Andrae; Julian Schulze; Babette Renneberg
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2014-12-18

5.  Proposed Diagnostic Criteria for the DSM-5 of Nonsuicidal Self-Injury in Female Adolescents: Diagnostic and Clinical Correlates.

Authors:  Tina In-Albon; Claudia Ruf; Marc Schmid
Journal:  Psychiatry J       Date:  2013-07-31

6.  Feeling excluded no matter what? Bias in the processing of social participation in borderline personality disorder.

Authors:  Anna Weinbrecht; Michael Niedeggen; Stefan Roepke; Babette Renneberg
Journal:  Neuroimage Clin       Date:  2018-04-26       Impact factor: 4.881

7.  PRO*BPD: effectiveness of outpatient treatment programs for borderline personality disorder: a comparison of Schema therapy and dialectical behavior therapy: study protocol for a randomized trial.

Authors:  Eva Fassbinder; Nele Assmann; Anja Schaich; Kristin Heinecke; Till Wagner; Valerija Sipos; Kamila Jauch-Chara; Michael Hüppe; Arnoud Arntz; Ulrich Schweiger
Journal:  BMC Psychiatry       Date:  2018-10-19       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.